Copyright Reports & Markets. All rights reserved.

Global Cerebral Embolic Protection Devices for TAVI Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cerebral Embolic Protection Devices for TAVI Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Total Artery Coverage
    • 1.3.3 Non-total Artery Coverage
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cerebral Embolic Protection Devices for TAVI Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hopsital
    • 1.4.3 Others
  • 1.5 Global Cerebral Embolic Protection Devices for TAVI Market Size & Forecast
    • 1.5.1 Global Cerebral Embolic Protection Devices for TAVI Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Cerebral Embolic Protection Devices for TAVI Sales Quantity (2021-2032)
    • 1.5.3 Global Cerebral Embolic Protection Devices for TAVI Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Boston Scientific (Claret Medical)
    • 2.1.1 Boston Scientific (Claret Medical) Details
    • 2.1.2 Boston Scientific (Claret Medical) Major Business
    • 2.1.3 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product and Services
    • 2.1.4 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Boston Scientific (Claret Medical) Recent Developments/Updates
  • 2.2 Venus Medtech (Keystone Heart)
    • 2.2.1 Venus Medtech (Keystone Heart) Details
    • 2.2.2 Venus Medtech (Keystone Heart) Major Business
    • 2.2.3 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product and Services
    • 2.2.4 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Venus Medtech (Keystone Heart) Recent Developments/Updates
  • 2.3 Transverse Medical
    • 2.3.1 Transverse Medical Details
    • 2.3.2 Transverse Medical Major Business
    • 2.3.3 Transverse Medical Cerebral Embolic Protection Devices for TAVI Product and Services
    • 2.3.4 Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Transverse Medical Recent Developments/Updates
  • 2.4 Emboline
    • 2.4.1 Emboline Details
    • 2.4.2 Emboline Major Business
    • 2.4.3 Emboline Cerebral Embolic Protection Devices for TAVI Product and Services
    • 2.4.4 Emboline Cerebral Embolic Protection Devices for TAVI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Emboline Recent Developments/Updates
  • 2.5 Protembis GmbH
    • 2.5.1 Protembis GmbH Details
    • 2.5.2 Protembis GmbH Major Business
    • 2.5.3 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product and Services
    • 2.5.4 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Protembis GmbH Recent Developments/Updates
  • 2.6 Filterlex Medical
    • 2.6.1 Filterlex Medical Details
    • 2.6.2 Filterlex Medical Major Business
    • 2.6.3 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product and Services
    • 2.6.4 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Filterlex Medical Recent Developments/Updates

3 Competitive Environment: Cerebral Embolic Protection Devices for TAVI by Manufacturer

  • 3.1 Global Cerebral Embolic Protection Devices for TAVI Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Manufacturer (2021-2026)
  • 3.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Cerebral Embolic Protection Devices for TAVI by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Cerebral Embolic Protection Devices for TAVI Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Cerebral Embolic Protection Devices for TAVI Manufacturer Market Share in 2025
  • 3.5 Cerebral Embolic Protection Devices for TAVI Market: Overall Company Footprint Analysis
    • 3.5.1 Cerebral Embolic Protection Devices for TAVI Market: Region Footprint
    • 3.5.2 Cerebral Embolic Protection Devices for TAVI Market: Company Product Type Footprint
    • 3.5.3 Cerebral Embolic Protection Devices for TAVI Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cerebral Embolic Protection Devices for TAVI Market Size by Region
    • 4.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Cerebral Embolic Protection Devices for TAVI Consumption Value by Region (2021-2032)
    • 4.1.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Region (2021-2032)
  • 4.2 North America Cerebral Embolic Protection Devices for TAVI Consumption Value (2021-2032)
  • 4.3 Europe Cerebral Embolic Protection Devices for TAVI Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Cerebral Embolic Protection Devices for TAVI Consumption Value (2021-2032)
  • 4.5 South America Cerebral Embolic Protection Devices for TAVI Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Cerebral Embolic Protection Devices for TAVI Sales Quantity by Type (2021-2032)
  • 5.2 Global Cerebral Embolic Protection Devices for TAVI Consumption Value by Type (2021-2032)
  • 5.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Cerebral Embolic Protection Devices for TAVI Sales Quantity by Application (2021-2032)
  • 6.2 Global Cerebral Embolic Protection Devices for TAVI Consumption Value by Application (2021-2032)
  • 6.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Cerebral Embolic Protection Devices for TAVI Sales Quantity by Type (2021-2032)
  • 7.2 North America Cerebral Embolic Protection Devices for TAVI Sales Quantity by Application (2021-2032)
  • 7.3 North America Cerebral Embolic Protection Devices for TAVI Market Size by Country
    • 7.3.1 North America Cerebral Embolic Protection Devices for TAVI Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Cerebral Embolic Protection Devices for TAVI Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Cerebral Embolic Protection Devices for TAVI Sales Quantity by Type (2021-2032)
  • 8.2 Europe Cerebral Embolic Protection Devices for TAVI Sales Quantity by Application (2021-2032)
  • 8.3 Europe Cerebral Embolic Protection Devices for TAVI Market Size by Country
    • 8.3.1 Europe Cerebral Embolic Protection Devices for TAVI Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Cerebral Embolic Protection Devices for TAVI Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cerebral Embolic Protection Devices for TAVI Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Cerebral Embolic Protection Devices for TAVI Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Cerebral Embolic Protection Devices for TAVI Market Size by Region
    • 9.3.1 Asia-Pacific Cerebral Embolic Protection Devices for TAVI Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Cerebral Embolic Protection Devices for TAVI Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Cerebral Embolic Protection Devices for TAVI Sales Quantity by Type (2021-2032)
  • 10.2 South America Cerebral Embolic Protection Devices for TAVI Sales Quantity by Application (2021-2032)
  • 10.3 South America Cerebral Embolic Protection Devices for TAVI Market Size by Country
    • 10.3.1 South America Cerebral Embolic Protection Devices for TAVI Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Cerebral Embolic Protection Devices for TAVI Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Market Size by Country
    • 11.3.1 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Cerebral Embolic Protection Devices for TAVI Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Cerebral Embolic Protection Devices for TAVI Market Drivers
  • 12.2 Cerebral Embolic Protection Devices for TAVI Market Restraints
  • 12.3 Cerebral Embolic Protection Devices for TAVI Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cerebral Embolic Protection Devices for TAVI and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cerebral Embolic Protection Devices for TAVI
  • 13.3 Cerebral Embolic Protection Devices for TAVI Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cerebral Embolic Protection Devices for TAVI Typical Distributors
  • 14.3 Cerebral Embolic Protection Devices for TAVI Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cerebral Embolic Protection Devices for TAVI market size was valued at US$ 133 million in 2025 and is forecast to a readjusted size of US$ 455 million by 2032 with a CAGR of 19.4% during review period.
    Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.
    TAVI (transcatheter aortic valve implantation), as a minimally invasive treatment for high-risk elderly patients or patients with surgical risks, has become one of the important breakthroughs in the cardiovascular field in recent years. TAVI technology has not only significantly improved the safety and effectiveness of valve replacement therapy, but also greatly improved the quality of life of patients. However, there are certain risks in the TAVI operation, especially the risk of cerebral embolism, which has always been a challenge in clinical treatment. In order to effectively reduce the cerebral embolic events that may occur during TAVI surgery, cerebral embolic protection devices (CEPDs) came into being and became an important technical means to ensure the safety of TAVI treatment and patient prognosis.
    At present, with the widespread application and acceptance of TAVI technology, the market demand for cerebral embolic protection devices is also growing. During TAVI surgery, especially when valve implantation is performed through the femoral artery, tiny blood clots may fall off due to the operation of the valve implanter and catheter, thereby causing cerebral embolism. This cerebral embolic event can cause stroke or other neurological complications, affecting the patient's prognosis. In order to effectively prevent this risk, CEPDs came into being and quickly became one of the standard configurations in TAVI surgery.
    Brain
    Globally, the European and American markets started early in the application of TAVI technology and related protection devices, and the market acceptance is high. Especially in the United States and Europe, more and more TAVI surgeries are beginning to routinely use cerebral embolic protection devices. In China and other Asian regions, with the gradual popularization of TAVI technology, the market demand for cerebral embolic protection devices is also rising. Although it is still in its infancy compared to the European and American markets, with the continuous advancement of medical technology and health concepts, the market potential is huge.
    Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.
    This report is a detailed and comprehensive analysis for global Cerebral Embolic Protection Devices for TAVI market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cerebral Embolic Protection Devices for TAVI market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Cerebral Embolic Protection Devices for TAVI market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Cerebral Embolic Protection Devices for TAVI market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Cerebral Embolic Protection Devices for TAVI market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cerebral Embolic Protection Devices for TAVI
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cerebral Embolic Protection Devices for TAVI market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boston Scientific (Claret Medical), Venus Medtech (Keystone Heart), Transverse Medical, Emboline, Protembis GmbH, Filterlex Medical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Cerebral Embolic Protection Devices for TAVI market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Total Artery Coverage
    Non-total Artery Coverage
    Market segment by Application
    Hopsital
    Others
    Major players covered
    Boston Scientific (Claret Medical)
    Venus Medtech (Keystone Heart)
    Transverse Medical
    Emboline
    Protembis GmbH
    Filterlex Medical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cerebral Embolic Protection Devices for TAVI product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cerebral Embolic Protection Devices for TAVI, with price, sales quantity, revenue, and global market share of Cerebral Embolic Protection Devices for TAVI from 2021 to 2026.
    Chapter 3, the Cerebral Embolic Protection Devices for TAVI competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cerebral Embolic Protection Devices for TAVI breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Cerebral Embolic Protection Devices for TAVI market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cerebral Embolic Protection Devices for TAVI.
    Chapter 14 and 15, to describe Cerebral Embolic Protection Devices for TAVI sales channel, distributors, customers, research findings and conclusion.

    Buy now